Immunogenicity and safety of the 15-valent pneumococcal conjugate vaccine, a systematic review and meta-analysis. [PDF]
Wagner G+18 more
europepmc +1 more source
Economic Evaluation of Transitioning to the 20-Valent Pneumococcal Conjugate Vaccine in the Dutch Paediatric National Immunisation Programme. [PDF]
Çakar E+6 more
europepmc +1 more source
Pneumococcal conjugate vaccines in different settings [PDF]
openaire +3 more sources
Similar Antibody Concentrations in Filipino Infants at Age 9 Months, after 1 or 3 Doses of an Adjuvanted, 11‐Valent Pneumococcal Diphtheria/Tetanus–Conjugated Vaccine: A Randomized Controlled Trial [PDF]
Marilla Lucero+5 more
openalex +1 more source
Correction to: Radiographically confirmed pneumonia in Malawian children and associated Pneumococcal carriage after introduction of the 13-valent Pneumococcal conjugate vaccine. [PDF]
Mzumara G+13 more
europepmc +1 more source
Accelerating Pneumococcal Conjugate Vaccine introductions in Indonesia: key learnings from 2017 to 2022. [PDF]
Athiyaman A+6 more
europepmc +1 more source
Azithromycin Modulates Murine Immune Responses to Pneumococcal Conjugate Vaccine and Inhibits Nasal Clearance of Bacteria [PDF]
Aracelis D. Fernandez+2 more
openalex +1 more source
Long-term impact of 10-valent pneumococcal conjugate vaccine among children <5 years, Uganda, 2014-2021. [PDF]
Wanyana MW+7 more
europepmc +1 more source